Casdin Capital is a New York-based fundamental research investment firm specializing in the life sciences and healthcare sectors. Established in 2012, the firm manages a multi-billion dollar long-short equity fund and engages in both early and late-stage private investments. Casdin is driven by curiosity and a commitment to understanding the life sciences ecosystem, focusing on identifying high-quality management teams and high-growth companies. The firm emphasizes data-driven decision-making, collaboration, and transparency while maintaining a long-term investment approach at the forefront of innovation.